Sponsor Deadline:
Sponsor:
UI Contact:
Updated Date:
View the three funding opportunities
Please note: Various deadlines for LOIs
The FY23 Defense Appropriations Act provides funding for the Ovarian Cancer Research Program (OCRP) to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service Members, Veterans, their family members, and all women impacted by this disease. The managing agent for the funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).
Applications submitted to the FY23 OCRP must address one or more of the following Areas of Emphasis:
- Understand the basic biology and etiology of ovarian cancer initiation, progression, metastasis, recurrence, genetics, proteogenomics and other critical events
- Develop novel therapeutic strategies for treatment and prevention
- Identify and develop new strategies for screening, early-stage detection, prevention, accurate diagnosis, and prognosis
- Identify and implement strategies to improve the survivorship and quality of life
- Address health disparities
- Improve precision medicine